297 related articles for article (PubMed ID: 2424237)
1. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome.
Statham BN; Rowell NR
Acta Derm Venereol; 1986; 66(2):139-43. PubMed ID: 2424237
[TBL] [Abstract][Full Text] [Related]
2. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
[TBL] [Abstract][Full Text] [Related]
3. [Vital microscopy of nailfold capillaries in progressive scleroderma in relation to the clinical picture].
Arizpe SR; Hornstein OP; Deinlein E
Z Hautkr; 1984 May; 59(9):593-600. PubMed ID: 6730614
[TBL] [Abstract][Full Text] [Related]
4. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
Maricq HR
Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
[TBL] [Abstract][Full Text] [Related]
5. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon.
Maricq HR; Weinberger AB; LeRoy EC
J Rheumatol; 1982; 9(2):289-91. PubMed ID: 7097688
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
7. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment.
Lee P; Leung FY; Alderdice C; Armstrong SK
J Rheumatol; 1983 Dec; 10(6):930-8. PubMed ID: 6663597
[TBL] [Abstract][Full Text] [Related]
8. [Capillary microscopy of the nail fold in Raynaud's phenomenon. Use in the early diagnosis of scleroderma].
Rivera Redondo J; López Bote JP; Alvaro-Gracia Alvaro JM; Sabando Suárez P; Ossorio Castellanos C
Rev Clin Esp; 1985 Jun; 177(1):7-10. PubMed ID: 4035042
[No Abstract] [Full Text] [Related]
9. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
10. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis.
DeBure C; Fiessinger JN; Priollet P; Camilleri JP; Vayssairat M; Kazandjian S; Housset E
J Rheumatol; 1985 Apr; 12(2):279-82. PubMed ID: 4032402
[TBL] [Abstract][Full Text] [Related]
11. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
12. [Capillaroscopy and Raynaud's phenomenon].
Carpentier P; Franco A
J Mal Vasc; 1984; 9(1):23-8. PubMed ID: 6707531
[TBL] [Abstract][Full Text] [Related]
13. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
14. Image analysis of nail fold capillaries in patients with Raynaud's phenomenon.
Ohtsuka T; Yamakage A; Tamura T
Cutis; 1995 Oct; 56(4):215-8. PubMed ID: 8575220
[TBL] [Abstract][Full Text] [Related]
15. Fine structural capillary changes and basal lamina thickening in scleroderma (progressive systemic sclerosis) and Raynaud's disease.
Camilleri JP; Fiessinger JN; Debure C; Bruneval P; Tricottet V; Kazandjian S; Housset E
Pathol Res Pract; 1984 Jan; 178(3):230-6. PubMed ID: 6718273
[TBL] [Abstract][Full Text] [Related]
16. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
Chamot AM; Monti M
Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
[TBL] [Abstract][Full Text] [Related]
17. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].
Cordioli E; Virgilio S; Ghirardi R; Martinelli M
Minerva Med; 1992 Nov; 83(11):739-44. PubMed ID: 1281297
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
19. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
20. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
